elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Chimeric antigen receptor
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Chimeric antigen receptor
RIS
0.001
(Research Intensity Score)
Papers
59
Top papers
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies
2024 · 81 citations
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
2021 · 263 citations
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma
2022 · 144 citations
In vivo imaging of nanoparticle-labeled CAR T cells
2022 · 140 citations
Smart CAR-T Nanosymbionts: archetypes and proto-models
2025 · 19 citations
Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control
2021 · 156 citations
Tumour priming by ultrasound mechanogenetics for CAR T therapy
2025 · 13 citations
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
2024 · 29 citations
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
2025 · 15 citations
Newest papers
Targeting immune checkpoint B7-H6 in cancer immunotherapy
2026
CD37 is a promising molecular target for CAR-T cells in chronic lymphocytic leukemia
2026
Natural killer cells at the interface of tumor immune escape and immunotherapy resistance in endometrial cancer
2026
Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance
2026 · 1 citations
CD19 CAR-T cell therapy in large B-cell lymphoma: clinical evidence, resistance, toxicity, and precision strategies
2026
Lymphocyte collection for cellular therapy
2026
PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED THERAPIES IN THE TREATMENT OF PROSTATE CANCER: ADVANCES, EFFICACY, AND FUTURE DIRECTIONS
2026
The Past, Present, and Future of PSMA-Targeted Therapies in Prostate Cancer
2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironment
2026
Browse all papers →
Chimeric antigen receptor's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Chimeric antigen receptor's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link